GLG1 and colorectal carcinoma: In contrast, GLG1 was not useful and non-significant for the discrimination of CRC (stages I and II) and premalignant individuals from controls (p-value = 0.9251) with AUC, sensitivity and specificity of 50.78%, 54.79%, and 50%, respectively (Figure 7D).